Modern trends in the treatment of endometriosis

Adamyan L.V.; Arslanyan K.N.; Kharchenko E.I.; Loginova O.N.

doi:https://doi.org/10.17116/repro20192506158

Close metadata

Recommended articles:

Oxidative stress, ferroptosis, somatic mutations, antioxidant therapy, and endometriosis: a new perspective on the issue. Russian Journal of Human Reproduction. 2024;(6):32-44

Modern view on the experimental creation of endometriosis in animal models (own data). Russian Journal of Human Reproduction. 2024;(6):55-60

Experimental modeling, prevention, and treatment of endometriosis-associated adhesion formation in NIH/3T3 fibroblast cell line using bovhyaluronidase azoximer (in vitro). Russian Journal of Human Reproduction. 2024;(6):61-72

Experience with the use of amitriptyline for chronic pelvic pain associated with endometriosis. Russian Journal of Human Reproduction. 2025;(1):86-93

Objectification of Pain in Patients with Endometriosis. (Literature review and own data). Russian Journal of Human Reproduction. 2025;(2):62-85

The role of macrophage polarization in the development of endometriosis and the therapeutic potential of its modulation. Russian Journal of Human Reproduction. 2025;(3):20-33

Experimental modeling and treatment of endometriosis using bovhyaluronidase azoximer in an animal model. Russian Journal of Human Reproduction. 2025;(4):26-40

Deep endometriosis — a comparative study of pain syndrome and the prevalence of clinical symptoms according to the #ENZIAN classification. Russian Journal of Human Reproduction. 2025;(4):96-101

Comparison of the main methods of surgical treatment of patients with colorectal endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):118-123

Use of gonadotropic releasing hormone agonists in hyperplastic syndrome in gynecology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58

Abstract:

This article discusses various areas of drug therapy of endometriosis. The modes, advantages and side effects of the drugs are described. The experience of Russian and foreign colleagues is presented.

Keywords:

endometriosis

conservative tactics

current trends

Authors:

Adamyan L.V.

Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Professional Education, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

SPIN RSCI: 9836-2713
Scopus AuthorID: 7006372422
ResearcherID: Q-1722-2018
ORCID: 0000-0002-3253-4512

Arslanyan K.N.

Kharchenko E.I.

Department of reproductive medicine and surgery University of Medicine and Dentistry, Moscow, Russia, 127473;
Perinatal Center of Vidnoye, Russia, 142700

Scopus AuthorID: 57180652400
ORCID: 0000-0002-3032-8416

Loginova O.N.

Kafedra reproduktivnoĭ meditsiny i khirurgii fakul'teta poslediplomnogo obrazovaniia Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Close metadata

References:

Taylor MM. Endometriosis — A Missed Malady. AORN Journal. 2003;77(2):297-313. https://doi.org/10.1016/s0001-2092(06)61201-5
Mueck OA. Dienogest: an oral progestogen for the treatment of endometriosis. Expert Review of Obstetrics and Gynecology. 2011;6(1):5-15. https://doi.org/10.1586/eog.10.71
Outley J, Gao C, Simon J, Spalding J, Botteman M. Health-Related Quality of Life Burden for Women With Endometriosis. Obstetrics and Gynecology. 2006;107(Suppl.):22S. https://doi.org/10.1097/00006250-200604001-00051
Bergqvist A, Theorell T. Changes in quality of life after hormonal treatment of endometriosis. Acta Obstetricia et Gynecologica Scandinavica. 2001;80(7):628-637. https://doi.org/10.1034/j.1600-0412.2001.800708.x
Dessole M, Melis GB, Angioni S. Endometriosis in adolescence. Obstetrics and Gynecology International. 20124;869-191. https://doi.org/10.1155/2012/869191
Adamyan LV, Sonova MM, Tikhonova ES, Antonova SO. Medical and social aspects of genital endometriosis. Problemy reproduktsii. 2011;6:78-81. (In Russ.)
Guidice LC. Endometriosis. New England Journal of Medicine. 2010;362:2389-2398. https://doi.org/10.1056/NEJMcp1000274
Adamyan LV, Osipova AA, Sonova MM. The evolution of hormonal therapy of endometriosis. Problemy reproduktsii. 2006;5:11-16. (In Russ.)
Endometrioz: diagnostika, lechenie i reabilitaciya: Federal’nyye klinicheskiye rekomendatsii po vedeniyu bol’nykh. M. 2016. (In Russ.)
Vercellini P, Crosignani PG, Abbiati A, Somigliana E, Viganò P, Fedele L. The effect of surgery for symptomatic endometriosis: the other side of the story. Human Reproduction Update. 2009;15(2):177-188. https://doi.org/10.1093/humupd/dmn062
Falcone T, Lebovic DI. Clinical management of endometriosis. Obstetrical and Gynecological Survey. 2011;118(3):691-705. https://doi.org/10.1097/AOG.0b013e31822adfd1
Burlev VA, Shorokhova MA, Samoylova TE. Modern principles of the pathogenetic treatment of endometriosis. Consilium Medicum. 2007;9(6):8-12. (In Russ.)
Shorokhova MA, Burlev VA, Samoylova TE. Pathogenetic substantiation of modern principles of treatment of patients with endometriosis: pros and cons. Rossiyskiy vestnik akushera-ginekologa. 2008;8(4):23-30. (In Russ.)
Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24 week, randomized, multicentre, open label trial. Human Reproduction. 2010;25(3):633-641. https://doi.org/10.1093/humrep/dep469
Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, Terakawa N. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis — a randomized, doubleblind, multicenter, controlled trial. Fertility and Sterility. 2009;91(3):675-681. https://doi.org/10.1016/j.fertnstert.2007.12.080
Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa E Silva JC, Podgaec S, Bahamondes L. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Human Reproduction. 2005;20(7):1993-1998. https://doi.org/10.1093/humrep/deh869
Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. Human Reproduction Update. 2006;12(2):179-189. https://doi.org/10.1093/humupd/dmi049
Sitruk-Ware R, Nath A. The use of newer progestins for contraception. Contraception. 2010;82(5):410-417. https://doi.org/10.1016/j.contraception.2010.04.004
Sol’skiy SYa, Sol’skiy VS. Features of the effectiveness of the combined treatment of external genital endometriosis. Zhurnal akusherstva i zhenskikh bolezney. 2009;58(5):79. (In Russ.)
Radzinskiy VE, Khamoshina MB. Endometriosis: to treat or not to treat, and if so, with what. Farmateka. 2009;9(183):64-67. (In Russ.)
Pavlov RV, Sel’kov SA, Pydra AR, Kundokhova MS. Ispol’zovanie ronkolejkina v kompleksnoj terapii naruzhnogo genital’nogo endometrioza. Materialy XI Vserossiyskogo nauchnogo foruma «Mat’ i ditya». 28 sentyabrya — 01 oktyabrya. M. 2010. Accessed September 30, 2019. (In Russ.) Available at: http://ncagip.ru/for-experts/seminars/archive/ 1337.html
Malyshkina AI, Sotnikova NYu, Antsiferova YuS. Immunomodulyatory v lechenii naruzhnogo genital’nogo endometrioza. Materialy XI Vserossiyskogo nauchnogo foruma «Mat’ i ditya». 28 sentyabrya — 01 oktyabrya. M. 2010. Accessed September 30, 2019. (In Russ.) Available at: http://ncagip.ru/for-experts/seminars/archive/ 1337.html
Sonova MM, Arslanyan KN, Loginova ON, Maksimova YuV, Murdalova ZKh, Shulyak IYu. Optimizaciya lecheniya naruzhnogo genital’nogo endometrioza s ispol’zovaniem antioksidantnyh sredstv. Novye tekhnologii v diagnostike i lechenii ginekologicheskih zabolevanij. XXIII Mezhdunarodnyy kongress s kursom endoskopii. 8 — 10 iyunya. M. 2010. (In Russ.)
Yarmolinskaya MI, Shved NYu, Ivashchenko TE, Baranov VS, Sel’kov SA. Znachenie geneticheskih i immunologicheskih faktorov v patogeneze lecheniya genital’nogo endometrioza. Materialy XI Vserossiyskogo nauchnogo foruma «Mat’ i ditya». 28 sentyabrya — 01 oktyabrya. M. 2010. Accessed September 30, 2019. (In Russ.). Available at: http://ncagip.ru/for-experts/seminars/archive/1337.html
Kohler G, Faustmann TA, Gerlinger C, Seitz C, Mueck AO. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. International Journal of Gynecology and Obstetrics. 2010;108(1):21-25. https://doi.org/10.1016/j.ijgo.2009.08.020
Howard FM. Endometriosis and mechanisms of pelvic pain. Journal of Minimally Invasive Gynecology. 2009;16:540-550. https://doi.org/10.1016/j.jmig.2009.06.017
Hey-Cunningham AJ, Peters KM, Barrera-Villa Zevallos H, Berbic M, Markham R, Fraser IS. Angiogenesis, lymphangiogenesis and neurogenesis in endometriosis. Frontiers in Bioscience. 2013; E5(3):1033-1056. https://doi.org/10.2741/e682
McCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs. 2010;70(16):2073-2088. https://doi.org/10.2165/11206320-000000000-00000
McKinnon BD, Bertschi D, Bersinger NA, Mueller MD. Inflammation and nerve fiber interaction in endometriotic pain. Trends in Endocrinology and Metabolism. 2015;26(1):1-10. https://doi.org/10.1016/j.tem.2014.10.003
Han SJ, O’Malley BW. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis. Human Reproduction Update. 2014;20(4):467-484. https://doi.org/10.1093/humupd/dmu002
Guo S-W. Nuclear factor-kappaB (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecologic and Obstetric Investigation. 2007;63(2):71-97. https://doi.org/10.1159/000096047
Andres M, Lopes L, Baracat E, Podgaec S. Dienogest in the treatment of endometriosis: systematic review. Archives of Gynecology and Obstetrics. 2015;292(3):523-529. https://doi.org/10.1007/s00404-015-3681-6
Katsuki Y, Takano Y, Futamura Y, Shibutani Y, Aoki D, Udagawa Y, Nozawa S. Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. Archives of Gynecology and Obstetrics. 1998;138(2):216-226. https://doi.org/10.1530/eje.0.1380216
Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertility and Sterility. 2005;83(5):1530-1535. https://doi.org/10.1016/j.fertnstert.2004.11.042
Grandi G, Xholli A, Napolitano A, Palma F, Cagnacci A. Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive: A Patient-Preference Prospective 24-Week Pilot Study. Reproductive Sciences. 2014;22(5):626-632. https://doi.org/10.1177/1933719114556488
Mita S, Shimizu Y, Sato A, Notsu T, Imada K, Kyo S. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β. Fertility and Sterility. 2014;101(2):595-601.e1. https://doi.org/10.1016/j.fertnstert.2013.10.038
Mori T, Ito F, Matsushima H, Takaoka O, Koshiba A, Tanaka Y, Kusuki I, Kitawaki J. Dienogest reduces HSD17β1 expression and activity in endometriosis. Journal of Endocrinology. 2015;225(2):69-76. https://doi.org/10.1530/joe-15-0052
Rzheznikov VM, Golubovskaya LYe, Minaylova ON, Grinenko GS, Korhov VV, Lesik EA, Petrosyan MA. Sostav, obladayushchij kontraceptivnoj aktivnost’yu. Patent RF na izobreteniye №2238095/20. 10.2004. Byul. №34. Accessed September 30, 2019. (In Russ.). Available at:] http://bd.patent.su/2238000-2238999/pat/servl/servleted4d.html.
Suknovalova MV, Bekhbudova LKh, Klimenko MP, Kappusheva LM, Kareva EN, Shimanovskij NL, Savel’eva GM. Relative binding activity of dydrogesterone with progesterone receptors of mononuclear cells of peripheral blood of patients included in the IVF program. Eksperimental’naya i klinicheskaya farmakologiya. 2013;76(7):24-26. (In Russ.)
Fedotcheva TA, Odintsova YeV, Shimanovskiy NL. Molecular mechanisms of the cytostatic and chemosensitizing effects of gestagens. Vestnik Rossiyskoy akademii meditsinskikh nauk. 2010;9:42-50. (In Russ.)
Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2008;61(1-2):171-180.
Sergeyev PV, Fedotcheva TA, Rzheznikov VM, Grinenko GS, Semejkin AV, Vetchinkina VB. New domestic gestagen with antitumor activity. Vestnik Rossiyskoy akademii meditsinskikh nauk. 2007;5:27-32. (In Russ.)
Bhattacharya S, Middleton LJ, Tsourapas A, Lee AJ, Champaneria R, Daniels JP, Roberts T, Hilken NH, Barton P, Gray R, Khan KS, Chien P, O’Donovan P, Cooper KG; International Heavy Menstrual Bleeding Individual Patient Data Metaanalysis Collaborative Group, Abbott J, Barrington J, Bhattacharya S, Bongers MY, Brun JL, Busfield R, Clark TJ, Cooper J, Cooper KG, Corson SL, Dickersin K, Dwyer N, Gannon M, Hawe J, Hurskainen R, Meyer WR, O’Connor H, Pinion S, Sambrook AM, Tam WH, van Zon-Rabelink IA, Zupi E. Cooper and the International Heavy Menstrual Bleeding Individual Patient Data Metaanalysis Collaborative Group Hysterectomy, endometrial ablation and Mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technology Assessment. 2011;15(19):111-252. https://doi.org/10.3310/hta15190
Nelson A. Levonorgestrel intrauterine: a first-line medical treatment for heavy menstrual bleeding. Women’s Health. 2010;6(3):347-356. https://doi.org/10.2217/whe.10.16
Andreeva EN. Pharmacoeconomic assessment of the use of various treatments for menorrhagia. Problemy reproduktsii. 2011;4:48-54. (In Russ.)
Mezhevitinova EA. Fertility after cessation of contraception. Ginekologiya. 2012;14(2):48-51. (In Russ.)
Prilepskaya VN, Letunovskaya AB. Menorrhagia and intrauterine hormonal releasing system. Ginekologiya. 2011;13:5:2-4. (In Russ.)
Natsional’nyye meditsinskiye kriterii priyemlemosti metodov kontratseptsii (rabochiy variant). M. 2012. Accessed September 30, 2019. (In Russ.). Available at: http://libed.ru/knigi-nauka/726663-8
Prilepskaya VN, Mezhevitinova EA, Nazarova NM, Bostandzhyan LL. Gormonal’naya kontracepciya. M.: GEOTAR-Media, 2011; 156-158. (In Russ.)
Radzinskiy VE. Akusherskaya agressiya. M.: Mediabyuro Status Praesens, 2011. (In Russ.)
Savel’yeva IS. The illusion of security. Status Praesens. 2011;3(6):81-85. (In Russ.)
Talibov OB. Dokazatel’naya meditsina v ginekologii. M.: Bayer, 2011. (In Russ.)
Nazarenko TA, Durinyan ER, Revishvili NA, Mishieva NG. Modern approaches to the use of progestins in women of reproductive age. Vestnik reproduktivnogo zdorov’ya. 2010;3(4):6-8. (In Russ.)
Orlova SA, Balan VYe, Levkovich YeA. Current trends in drug treatment of endometriosis. Meditsinskiy sovet. 2015;20:28-33. (In Russ.)
Andreeva EN, Gavrilova EF. Genital endometriosis: solutions to the 21st century. Vestnik reproduktivnogo zdorov’ya; 2011;2:3-10. (In Russ.)
Bakhareva IV. Vitamin D and endometriosis: in search of new opportunities. Rossiyskiy vestnik akushera-ginekologa. 2018;18(4):35-43. (In Russ.) https://doi.org/10.17116/rosakush201818435
Shestakova IG, Kasyan VN, Bril’ YuA. V pervoj linii terapii? Naznachenie KOK zhenshchinam reproduktivnogo vozrasta s endometriozom. Informatsionnyy byulleten’. Pod red. Radzinskogo VE. Status Praesens. 2018. (In Russ.)